Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Denali Therapeutics Inc. (DNLI)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and DNLI | ||
|---|---|---|
| S&P 500 | DNLI | |
| Start Date | Jan-01-2018 | Jan-31-2018 |
| Start Price | $2,581.86 | $23.26 |
| End Date | Jul-01-2024 | Jul-26-2024 |
| End Price | $5,475.09 | $24.10 |
| Number Monthly Prices | 79 | 79 |
| Min Date | Dec-01-2018 | Jul-31-2018 |
| Min Price | $3,185.80 | $12.59 |
| Max Date | Jul-01-2024 | Dec-31-2020 |
| Max Price | $5,475.09 | $83.76 |
| Total Return | 56.03% | 3.61% |
| Annualized Return | 6.99% | 0.54% |
| Current Value of $1,000 Purchase | $1,560 | $1,036 |
| Number Returns | 3,081 | 3,081 |
| Average Return | 16.75% | 32.64% |
| Minimum Return | -25.54% | -81.57% |
| Maximum Return | 71.86% | 565.29% |
| Number Profitable Returns | 2,498 | 1,713 |
| Percent Profitable Returns | 81.08% | 55.60% |
| Number Unprofitable Returns | 583 | 1,368 |
| Percent Unprofitable Returns | 18.92% | 44.40% |
| Profitable to Unprofitable Returns Ratio | 4.28 | 1.25 |
DNLI Performance Table and Chart
DNLI Dollar-cost Average
DNLI Trendline Chart
DNLI Moving Average Chart
DNLI Stock Return Map - See Patterns of Gains and Losses
DNLI Stock Returns/Purchase Dates